| Session | Speaker | Presentation |
M1 |
Stephan Ogenstad |
|
M-2 |
Dejun Tang |
|
M-3 |
Naitee Ting |
|
M-4 |
Mark J. van der Laan |
|
M-5 |
Michael O'Connell |
|
M-6 |
Ralph Raymond & Frank Shen |
|
M-7 |
Tim Montague |
|
Keynote Address |
Greg Campbell |
|
T-1 |
Rong Liu |
|
T-2 |
Julia Wang & Akiko Okamoto |
|
T-3 |
Robert E. Johnson |
|
T-4 |
Andrew Strahs |
|
T-5 |
Shein-Chung Chow & Mark Chang |
|
W-FDA |
Mohammad Huque |
|
| W-FDA | Guoxing (Greg) Soon | Issues and Considerations for Composite Endpoints Use in Clinical Trials |
| W-FDA | Atiar Rahman | Recent Results concerning Multiplicities in Animal Carcinogenicity Studies |
| W-FDA | Alex Dmitrienko | Tree-structured Gatekeeping Procedures in Clinical Trials with Multiple Objectives |